No significant difference in clinically relevant findings between Pillcam® SB3 and Pillcam® SB2 capsules in a United States veteran population

Table 2 Indications and findings of Pillcam^® SB3 vs Pillcam^® SB2 capsule studies

	Total	Pillcam® SB3	Pillcam® SB2	P value
	n (%)	n (%)	n (%)
Indication
Occult GIB	194 (74.6)	92 (70.8)	102 (78.5)	0.154
Overt GIB	38 (14.6)	24 (18.5)	14 (10.8)	0.079
Mass/Polyp	9 (3.5)	4 (3.1)	5 (3.8)	0.999
IBD	7 (2.7)	2 (1.5)	5 (3.8)	0.447
Other	12 (4.6)	8 (6.2)	4 (3.1)	0.237
Finding
Bleeding source1	100 (38.5)	47 (36.1)	53 (40.8)	0.444
IBD	9 (3.5)	3 (2.3)	6 (4.6)	0.500
Mass/Polyp	18 (6.9)	10 (7.7)	8 (6.2)	0.625
Change in clinical management	118 (45.4)	53 (40.8)	65 (50.0)	0.135
Clinically relevant finding	127 (48.9)	60 (46.2)	67 (51.5)	0.385

¹Blood in lumen, ulcerative disease, erosive disease, arteriovenous malformation. IBD: Inflammatory bowel disease; GIB: Gastrointestinal bleeding.